Triasima Portfolio Management Inc. Abbott Laboratories Transaction History
Triasima Portfolio Management Inc.
- $467 Million
- Q2 2025
A detailed history of Triasima Portfolio Management Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Triasima Portfolio Management Inc. holds 16,285 shares of ABT stock, worth $2.19 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
16,285Holding current value
$2.19 Million% of portfolio
0.47%Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,600Shares Held
1.4BCall Options Held
9.23MPut Options Held
8.1M-
Vanguard Group Inc Valley Forge, PA173MShares$23.3 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$10.5 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$8.09 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.62 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $236B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...